Continuous subcutaneous insulin infusion (CSII) is an effective method of insulin therapy in people with type 1 diabetes.1 Especially in children with diabetes, CSII is the method of choice.2 It allows a continuous basal insulin flow and additional bolus administration, whereby small frequent insulin microdoses can be administered and flexibly adjusted. The gene discussed is INS; the disease is diabetes mellitus.